methylamine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assenmacher, CA; Avadhani, NG; Chattopadhyay, M; Chowdhury, AR; Feng, T; Guengerich, FP; Radaelli, E | 1 |
| Dluzen, DE; Hu, YQ; Koo, PH; Liu, BJ | 1 |
2 other study(ies) available for methylamine and Parkinson Disease
| Article | Year |
|---|---|
Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cytochrome P-450 CYP2D6; Disease Models, Animal; Humans; Male; Methylamines; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Neuroblastoma; Neurons; Neurotoxins; Parkinson Disease; Tumor Cells, Cultured | 2019 |
Alteration of dopamine release by rat caudate putamen tissues superfused with alpha 2-macroglobulin.
Topics: alpha-Macroglobulins; Alzheimer Disease; Animals; Caudate Nucleus; Dopamine; Male; Methylamines; Nerve Growth Factors; Neurotoxins; Parkinson Disease; Perfusion; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Nerve Growth Factor; Stimulation, Chemical | 1996 |